3 results match your criteria: "Charité-Universitätsmedizin Berlin (Free University and Humboldt University)[Affiliation]"
Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials.
Arthritis Care Res (Hoboken)
March 2019
University of Queensland Brisbane, Rheumatology Research Unit Sunshine Coast, Brisbane, Queensland, Australia.
Objective: To evaluate ixekizumab safety in adults with psoriatic arthritis (PsA).
Methods: Safety data from 2 integrated data sets are presented: 1) 24-week, double-blind, placebo-controlled period of SPIRIT-P1 and SPIRIT-P2; and 2) all ixekizumab-treated patients of SPIRIT-P1 and SPIRIT-P2 plus SPIRIT-P3 open-label period. We report adverse event (AE) frequency and exposure-adjusted incidence rates per 100 patient-years at 12-week intervals to week 96.
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
J Rheumatol
February 2018
From the University of California at Los Angeles (UCLA), Los Angeles, California, USA; Leiden University Medical Center, Leiden, the Netherlands; Charité-University Medicine Berlin Free University and Humboldt University of Berlin, Berlin, Germany; Department of Medicine, University of Queensland, Queensland, Australia; Centro Paulista de Investigação Clinica, São Paulo, Brazil; Pfizer Inc., Groton, Connecticut; Pfizer Inc., Collegeville, Pennsylvania; Pfizer Inc., New York, New York; Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Objective: Tofacitinib has been investigated for the treatment of rheumatoid arthritis (RA) in phase III studies in which concomitant glucocorticoids (GC) were allowed. We analyzed the effect of GC use on efficacy outcomes in patients with RA receiving tofacitinib and/or methotrexate (MTX) or conventional synthetic disease-modifying antirheumatic drugs (csDMARD) in these studies.
Methods: Our posthoc analysis included data from 6 phase III studies (NCT01039688; NCT00814307; NCT00847613; NCT00853385; NCT00856544; NCT00960440).
Pediatricians' working conditions in German hospitals: a real-time task analysis.
Eur J Pediatr
May 2010
Institute of Occupational Medicine, Charité-Universitätsmedizin Berlin (Free University and Humboldt University), Thielallee 69-73, Berlin, Germany.
Surveys of pediatricians in Germany report low levels of job satisfaction. Preferably, such subjective reports should be corroborated by objective data regarding physicians' working conditions. However, such data in the field of pediatrics could not be found in the scientific literature.
View Article and Find Full Text PDF